COVID-19: ACQH, convalescent plasma trials to begin soon, says CSIR DG

May 21, 2020

New Delhi, May 21(ANI): Council of Scientific and Industrial Research (CSIR) Director-General Shekhar C Mande on ACQH trails for COVID-19 said that ACQH is a plant extract found in the tribal belt of Gujarat, Jharkhand and MP. He said, “Earlier, in a program for anti-dengue medicines, ACQH showed promising results. Based on those trials, we approached Drug Controller General of India for COVID-19 that’s what we are starting now.” CSIR DG further informed that CSIR-Indian Institute of Chemical Biology (IICB) in Kolkata got approval from DCGI to start therapy on convalescent plasma. “They've tied up with few hospitals in Kolkata and have begun the trials now,” he added.